Botanical double action in RA!
CJNM finds Murraya exotica extract reduces joint damage, inflammation and oxidative stress via NF-κB/AP-1. Murrayone is a key active compound.

We’re proud to announce that CJNM has been selected for the 2025 Directory of World-Class Scientific and Technological Journals.
CJNM’s latest JCR Impact Factor is 7.5, ranking Q1, 3/48 in Integrative & Complementary Medicine.
Nuciferine, a lotus-leaf alkaloid, targets insulin receptors to combat T2DM-related cognitive decline. It boosts IR/IRS1/IGF-1R, restores PI3K/AKT signaling, reduces yperphosphorylated Tau.